Karl Peggs
University College London
H-index: 76
Europe-United Kingdom
Top articles of Karl Peggs
Multinational Study Assessing Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Hematopoietic Stem Cell Transplant Recipients with Cytomegalovirus Infection …
Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
2024/2/1
Fcγ receptors and immunomodulatory antibodies in cancer
2024/1
AURORA: A New Dawn
Clinical Infectious Diseases
2024/4/4
Donor whole blood DNA methylation is not a strong predictor of acute graft versus host disease in unrelated donor allogeneic haematopoietic cell transplantation
medRxiv
2022
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir …
Clinical Infectious Diseases
2024/3/15
FC-optimeret anti-CD25 til tumorspecifik celledepletering
2024/2/26
Long-Term Efficacy and Safety of Obecabtagene Autoleucel (obe-cel) in Adult Patients (pts) with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia ([R/R B-ALL]; Pooled …
Blood
2023/11/28
1312 Identification and validation of immunogenic clonal neoantigens for personalized therapies
2023/11/1
Anti cd25 fc gamma receptor bispecific antibodies for tumor specific cell depletion
2023/8/24
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
Open Forum Infectious Diseases
2023/8
Avelumab monotherapy followed by a pet adapted chemotherapy approach in the first line treatment of classical hodgkin lymphoma: Initial results from the avenue window study
Hematological Oncology
2023/6
Modulation of t cell cytotoxicity and related therapy
2023/5/25
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
Blood, The Journal of the American Society of Hematology
2023/5/18
The evolution of lung cancer and impact of subclonal selection in TRACERx
Nature
2023/4/20
The evolution of non-small cell lung cancer metastases in TRACERx
Nature
2023/4/20
A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufacture
Cytotherapy
2023/3/1
AKT inhibition generates potent polyfunctional clinical grade AUTO1 CAR T-cells, enhancing function and survival
Journal for Immunotherapy of Cancer
2023
Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial
Cytotherapy
2023/1/1
Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
Nature cancer
2022/11
Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling
Nature cancer
2022/11
